Multiple mechanisms in the long-QT syndrome: Current knowledge, gaps, and future directions

Circulation

Volumn 94, Issue 8, 1996, Pages 1996-2012

  Roden, Dan M ^a   Lazzara, Ralph ^c   Rosen, Michael ^c   Schwartz, Peter J ^c   Towbin, Jeffry ^c   Michael Vincent, G ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LDS HOSPITAL   (United States)

^c NONE

Author keywords

arrhythmia; genes; long QT syndrome

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ION CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

ARRHYTHMOGENESIS; CHROMOSOME 11; CHROMOSOME 7; FAMILY HISTORY; GENE MUTATION; GENETIC LINKAGE; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SUDDEN DEATH; SYNCOPE; TORSADE DES POINTES;

EID: 0029847602     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.8.1996     Document Type: Review

References (169)

1. Schwartz PJ, Periti M, Malliani A. The long QT syndrome. Am Heart J. 1975;89:378-390.
2. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957;54:59-68.
3. Levine SA, Woodworth CR. Congenital deaf-mutism, prolonged QT interval, syncopal attacks and sudden death. N Engl J Med. 1958;259:412-417.
4. Fraser GR, Froggatt P, Murphy T. Genetical aspects of the cardioauditory syndrome of Jervell and Lange-Nielsen (congenital deafness and electrocardiographic abnormalities). Ann Hum Genet. 1964;28: 133-156.
5. Romano C. Gemme G, Pongiglione R. Aritmie cardiache rare in età pediatrica. Clin Pediatr. 1963;45:656-683.
6. Ward OC. A new familial cardiac syndrome in children. J Irish Med Assoc. 1964;54:103-106.
7. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399-411.
8. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation. 1993;88: 782-784.
9. Dessertenne F. La tachycardie ventriculaire à deux foyers opposés variables. Arch Mal Coeur. 1966;59:263-272.
10. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327:846-852.
11. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A Jr, Robinson JL, Benhorin J, Choi S. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136-1144.
12. Hashiba K. Hereditary QT prolongation syndrome in Japan: genetic analysis and pathological findings of the conducting system. Jpn Circ J. 1978;42:1133-1150.
13. Hashiba K. Sex differences in phenotypic manifestation and gene transmission in the Romano-Ward syndrome. Ann N Y Acad Sci. 1992;644:142-156.
14. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270:2590-2597.
15. De Ambroggi L, Bertoni T, Locati E, Stramba-Badiale M, Schwartz PJ. Mapping of body surface potentials in patients with the idiopathic long QT syndrome. Circulation. 1986;74:1334-1345.
16. Priori SG, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval: a marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation. 1994;89:1681-1689.
17. Malfatto G, Beria G, Sala S, Bonazzi O, Schwartz PJ. Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. J Am Coll Cardiol. 1994; 23:296-301.
18. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH, Keating MT, MacCluer JW, Timothy KW. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:2929-2934.
19. Nador F, Beria G, De Ferrari GM, Stramba-Badiale M, Locati EH, Lotto A, Schwartz PJ. Unsuspected echocardiographic abnormality in the long QT syndrome: diagnostic, prognostic, and pathogenetic implications. Circulation. 1991;84:1530-1542.
20. De Ferrari GM, Nador F, Beria G, Sala S, Lotto A, Schwartz PJ. Effect of calcium channel block on the wall motion abnormality of the idiopathic long QT syndrome. Circulation. 1994;89:2126-2132.
21. Schwartz PJ, Malliani A. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long QT syndrome. Am Heart J. 1975;89:45-50.
22. Zareba W, Moss AJ, Le Cessie S, Hall WJ. T wave alternans in idiopathic long QT syndrome. J Am Coll Cardiol. 1994;23:1541-1546.
23. Crampton RS. Preeminence of left stellate ganglion in the long QT syndrome. Circulation. 1979;59:769-778.
24. Jackman WM, Szabo B, Friday DJ, Margolis PD, Moulton K, Wang X, Patterson E, Lazzara R. Ventricular tachyarrhythmias related to early afterdepolarizations and triggered firing: relationship to QT interval prolongation and potential therapeutic role for calcium channel blocking agents. J Cardiovasc Electrophysiol. 1990;1: 170-195.
25. Shimizu W, One T, Kurita T, Tokuda T, Shimomura K. Epinephrine-induced ventricular premature complexes due to early after-depolarizations and effects of verapamil and propranolol in a patient with congenital long QT syndrome. J Cardiovasc Electrophysiol. 1994;5:438-444.
26. + channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation. 1995;92:3381-3386.
27. Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;285:903-904.
28. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome: a worldwide report. Circulation. 1991;84: 503-511.
29. Eldar M, Griffin JC, Abbott JA, Benditt D, Bhandari A, Herre JM, Benson DW, Scheinman MM. Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol. 1987;10:600-607.
30. Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation. 1991;84:1524-1529.
31. Fish FA, Prakash C, Roden DM. Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators. Circulation. 1990;82:1362-1369.
32. Ben-David J, Zipes DP. Alpha-adrenoceptor stimulation and blockade modulates cesium-induced early afterdepolarizations and ventricular tachyarrhythmias in dogs. Circulation. 1990;82:225-233.
33. Schwartz PJ, Bonazzi O, Locati E, Napolitano C, Sala S. Pathogenesis and therapy of the idiopathic long QT syndrome. Ann N Y Acad Sci. 1992;644:112-141.
34. Chezalviel-Guilbert F, Davy JM, Poirier JM, Weissenburger J. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes. J Am Coll Cardiol. 1995;26:787-792.
35. Sato T, Hata Y, Yamamoto M, Morita H, Mizuo K, Yamanari H, Saito D, Ohe T. Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome. J Cardiovasc Electrophysiol. 1995;6:279-282.
36. Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376: 683-685.
37. Bangalore R, An RH, Kass RS. Molecular pharmacology of an inherited heart disease. Biophys J. 1996;70:A260. Abstract.
38. + channel-linked long-QT syndrome. Circ Res. 1996;78:916-924.
39. + channel blockade, beta-adrenergic stimulation and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long QT syndrome. Circ Res. 1996;78:1009-1015.
40. Schwartz PJ, Locati EH, Napolitano C, Priori SG. The long QT syndrome. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1995: 788-811.
41. Dangman KH, Hoffman BF. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide. J Pharmacol Exp Ther. 1981;217:851-862.
42. Brachmann J, Scherlag BJ, Rosenshtraukh LV, Lazzara R. Brady-cardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia. Circulation. 1983;68:846-856.
43. Roden DM, Hoffman BF. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers: relationship to potassium and cycle length. Circ Res. 1985;56:857-867.
44. Strauss HC, Bigger JT, Hoffman BF. Electrophysiological and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res. 1970;26:661-678.
45. Brown B. Early afterdepolarizations induced by batrachotoxin: possible involvement of a sodium current. Fed Proc. 1983;42:521. Abstract.
46. El-Sherif N, Zeiler RH, Craelius W, Gough WB, Henkin R. QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Circ Res. 1988; 63:286-305.
47. 2+ channel agonist Bay K 8644. Circ Res. 1988;62:563-571.
48. 2+ current. Circ Res. 1989;64:977-990.
49. +-induced early afterdepolarizations in Purkinje fibers. J Cardiovasc Electrophysiol. 1994;5:933-944.
50. Zeng J, Rudy Y. Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys J. 1995;68:949-964.
51. Cinca J, Sassine A, Deceuninck P, Roca J, Gagne P, Morena H, Puech P. The dependence of T wave alternans on diastolic resting period duration. Eur J Cardiol. 1978;7:299-309.
52. Franz MR, Swerdlow CD, Liem LB, Schaefer J. Cycle length dependence of human action potential duration in vivo: effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest. 1988;82:972-979.
53. Saitoh H, Bailey JC, Surawicz B. Action potential duration alternans in dog Purkinje and ventricular muscle fibers: further evidence in support of two different mechanisms. Circulation. 1989;80:1421-1431.
54. + current in ventricular myocytes of the guinea pig type: theoretical formulation and their role in repolarization. Circ Res. 1995;77:140-152.
55. Duly SG, Lab MJ. Electrophysiological alternans and restitution during acute regional ischaemia in myocardium of anaesthetized pig. J Physiol. 1988;402:315-333.
56. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle: the M cell. Circ Res. 1991;68:1729-1741.
57. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by-afterdepolarizations: the role of M cells in the generation of U waves, triggered activity and torsades de pointes. J Am Coll Cardiol. 1994;23:259-277.
58. Antzelevitch C, Sicouri S, Lukas A, Nesterenko VV, Liu DW, Di Diego JM. Regional differences in the electrophysiology of ventricular cells: physiological and clinical implications. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1995:228-245.
59. D'Alnoncourt CN, Zierhut W, Luderitz B. Torsade de pointes' tachycardia: re-entry or focal activity? Br Heart J. 1982;48:213-216.
60. Leichter D, Danilo P Jr, Boyden P, Rosen TS, Rosen MR. A canine model of torsades de pointes. Pacing Clin Electrophysiol. 1988; 11:2235-2245.
61. Levine JH, Spear JF, Guarnieri T, Weisfeldt ML, De Langen CDJ, Becker LC, Moore EN. Cesium chloride-induced long QT syndrome: demonstration of afterdepolarizations and triggered activity in vivo. Circulation. 1985;72:1092-1103.
62. Pertsov AM, Davidenko JM, Salomonsz R, Baxter WT, Jalife J. Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res. 1993;72:631-650.
63. Gray RA, Jalife J, Panfilov A, Baxter WT, Cabo C, Davidenko JM, Pertsov AM. Nonstationary vortexlike reentrant activity as a mechanism of polymorphic ventricular tachycardia in the isolated rabbit heart. Circulation. 1995;91:2454-2469.
64. Campbell RW, Furniss SS. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation. Am J Cardiol. 1993;72:80A-85A.
65. Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes: disparate effects of class la antiarrhythmic drugs and amiodarone. Circulation. 1992;86:1376-1382.
66. Derakhchan K, Klug D, Bouchard C, Hélie F, Pharand C, Sasyniuk BI, Kus T, Cardinal R. Torsades de pointes induced by d-sotalol in canine atrio-ventricular block: initiation in the conduction system followed by spatially unstable reentry. Circulation. 1995;92(suppl I): I-640. Abstract.
67. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science. 1991;252:704-706.
68. + channels. Cell. 1990;61:769-776.
69. Roy N, Kahlem P, Dausse E, Bennaceur M, Fauré S, Weissenbach M, Komajda M, Denjoy I, Coumel P, Schwartz K, Guicheney P. Exclusion of Hras from the long QT locus. Nat Genet. 1994;8: 113-114.
70. Russell MW, Brody LC, Munroe D, Dick MI, Collins FS. Characterization of a recombination event excluding the Harvey-ras-1 (H-ras-1) locus in a Romano-Ward long QT syndrome family linked to chromosome 11p15 and isolation of a polymorphic repeat teleomeric to H-ras-1. Am J Hum Genet. 1994;55:A353. Abstract.
71. Schwartz K. On the pulse of genetic cardiology. Nature. 1994; 8:110-111.
72. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17-23.
73. Keating M, Dunn C, Atkinson D, Timothy K, Vincent GM, Leppert M. Consistent linkage of the long-QT syndrome to the Harvey ras-I locus on chromosome 11. Am J Hum Genet. 1991;49:1335-1339.
74. Towbin JA, Pagotta L, Siu B, Robinson J, Moss A, McCabe ERB, Hejtmancik JF. Romano-Ward long QT syndrome: evidence of genetic heterogeneity. Pediatr Res. 1992;31:23A. Abstract.
75. Benhorin J, Kalman YM, Medina A, Towbin J, Rave-Harel N, Dyer TD, Blangero J, MacCluer JW, Kerem BS. Evidence of genetic heterogeneity in the long QT syndrome. Science. 1993; 260:1960-1962.
76. Curran M, Atkinson D, Timothy K, Vincent GM, Moss AJ, Leppert M, Keating M. Locus heterogeneity of autosomal dominant long QT syndrome. J Clin Invest. 1993;92:799-803.
77. Dean JC, Cross S, Jennings K. Evidence of genetic and phenotypic heterogeneity in the Romano-Ward syndrome. J Med Genet. 1993; 30:947-950.
78. Akimoto K, Matsuoka R, Kasanuki H, Takao A, Monma K, Hayakawa K, Hosoda S. Linkage analysis in a Japanese long QT syndrome family. Kokyuto Junkan - Respir Circ. 1993;41:463-465.
79. Towbin JA, Li H, Taggart RT, Lehmann MH, Schwartz PJ, Satler CA, Ayyagari R, Robinson JL, Moss AJ, Hejtmancik JF. Evidence of genetic heterogeneity in Romano-Ward long QT syndrome: analysis of 23 families. Circulation. 1994;90:2635-2644.
80. Jiang C, Atkinson D, Towbin JA, Splawski I, Lehmann MH, Li H, Timothy K, Taggart RT, Schwartz PJ, Vincent GM, Moss AJ, Keating MT. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet. 1994;8: 141-147.
81. Schott JJ, Charpentier F, Peltier S, Foley P, Drouin E, Bouhour JB, Donnelly P, Vergnaud G, Bachner L, Moisan JP, Le Marec H, Pascal O. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet. 1995;57:1114-1122.
82. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795-803.
83. 82a. Benson DW, MacRae CA, Vesely MR, Walsh EP, Seidman JG, Seidman CE, Satler CA. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation. 1996;93: 1791-1795.
84. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80: 805-811.
85. Papazian DM, Schwarz TL, Tempel BL, Jan YN, Jan LY. Cloning of genomic and complementary DNA from Shaker, a putative potassium channel gene from Drosophila. Science. 1987;237:749-753.
86. + channel cDNAs from human ventricle. FASEB J. 1991; 5:331-337.
87. Warmke J, Drysdale R, Ganetzky B. A distinct potassium channel polypeptide encoded by the Drosophila eag locus. Science. 1991; 252:1560-1562.
88. Warmke JW, Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci U S A. 1994;91:3438-3442.
89. Kr potassium channel. Cell. 1995;81:299-307.
90. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science. 1995;269:92-95.
91. + current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990;96:195-215.
92. + channel: open channel block by methanesulfonanilides. Circ Res. 1996;78:499-503.
93. + currents. Pflugers Arch. 1992;420:180-186.
94. Kr: implications for torsades de pointes and reverse use-dependence. Circulation. 1996;93:407-411.
95. 93a. Compton SJ, Lux RL, Ramsay MR, Strelich KT, Sanguinetti MC, Keating MT, Mason JW. Gene-derived therapy in inherited long QT syndrome: correction of abnormal repolarization by potassium. Pacing Clin Electrophysiol. 1996;19:642. Abstract.
96. Colatsky TJ, Follmer CH, Starmer CF. Channel specificity in antiarrhythmic drug action: mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation. 1990;82:2235-2242.
97. Sanguinetti MC, Jurkiewicz NK, Scott A, Siegl PKS. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes: mechanism of action. Circ Res. 1991;68:77-84.
98. Miller C. Annus mirabilis of potassium channels. Science. 1990; 252:1092-1096.
99. MacKinnon R. Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature. 1991;350:232-235.
100. + channel beta subunit expressed in human heart. Proc Natl Acad Sci U S A. 1995;92: 6309-6313.
101. Morales MJ, Castellino RC, Crews AL, Rasmusson RL, Strauss HC. A novel β subunit increases rate of inactivation of specific voltage-gated potassium channel α subunits. J Biol Chem. 1995; 270:6272-6277.
102. Majumder K, De Biasi M, Wang Z, Wible BA. Molecular cloning and functional expression of a novel potassium channel beta-subunit from human atrium. FEBS Lett. 1995;361:13-16.
103. + channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A. 1996;93:2208-2212.
104. Roden DM. Current status of class III antiarrhythmic therapy. Am J Cardiol. 1993;72:44B-49B.
105. Echt DS, Lee JT, Murray KT, Vorperian V, Borganelli SM, Crawford DM, Friedrich T, Roden DM. A randomized, double-blind, placebo-controlled, dose-ranging study of dofetilide in patients with inducible sustained ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 1995;6:687-699.
106. Wiesfeld AC, Crijns HJ, Bergstrand RH, Almgren O, Hillege HL, Lie KI. Torsades de pointes with almokalant, a new class III antiarrhythmic drug. Am Heart J. 1993;126:1008-1011.
107. Wang Z, Fermini B, Nattel S. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther. 1995;272:184-196.
108. Carmeliet E. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol Exp Ther. 1985;232:817-825.
109. + current in guinea pig ventricular cells. J Pharmacol Exp Ther. 1992;262:99-108.
110. Kr) in AT-1 cells: concentration-, time-, voltage-, and use-dependent effects. Circulation. 1995;91:1799-1806.
111. Locati EH, Maison-Blanche P, Dejode P, Cauchemez B, Coumel P. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Hotter recordings. J Am Coll Cardiol. 1995;25:1564-1575.
112. Kubo Y, Reuveny E, Slesinger PA, Jan YN, Jan LY. Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel. Nature. 1993;364:802-806.
113. Ho K, Nichols CG, Lederer WJ, Lytton J, Vassilev PM, Kanazirska MV, Hebert SC. Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature. 1993;362:31-38.
114. + channel from human atrium. Circ Res. 1995;76:343-350.
115. +-channel proteins. Nature. 1995;374:135-141.
116. Takumi T, Ohkubo H, Nakanishi S. Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science. 1988; 242:1042-1045.
117. Folander K, Smith JS, Antanavage J, Bennett C, Stein RB, Swanson R. Cloning and expression of the delayed rectifier IsK channel from neonatal rat heart and diethylstilbestrol-primed rat uterus. Proc Natl Acad Sci U S A. 1990;87:2975-2979.
118. + channel in mouse heart. EMBO J. 1991;10:2805-2811.
119. - channels. Nature. 1993;365:850-852.
120. + current. Circ Res. 1995;77:1246-1253.
121. Yue DT, Marban E. A novel cardiac potassium channel that is active and conductive at depolarized potentials. Pflugers Arch. 1988;413: 127-133.
122. Hume JR, Harvey RD. Chloride conductance pathways in heart. Am J Physiol. 1991;261:C399-C412.
123. Jentsch TJ, Gunther W, Pusch M, Schwappach B. Properties of voltage-gated chloride channels of the ClC gene family. J Physiol. 1995;482:19S-25S.
124. - channels in heart. Circ Res. 1992;71:1002-1007.
125. Van Wagoner DR. Mechanosensitive gating of atrial ATP-sensitive potassium channels. Circ Res. 1993;72:973-983.
126. Weiss JN, Nademanee K, Stevenson WG, Singh B. Ventricular arrhythmias in ischemic heart disease. Ann Intern Med. 1991;114: 784-797.
127. + channels. Cardiovasc Drugs Ther. 1993;7(suppl 3): 499-505.
128. + channels in the heart. Prog Clin Biol Res. 1990;334:85-109.
129. Wang Q, Shen J, Li Z, Timothy K, Vincent GM, Priori SG, Schwartz PJ, Keating MT. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet. 1995;4:1603-1607.
130. +)-channel inactivation. Proc Natl Acad Sci U S A. 1992;89: 10910-10914.
131. + channel inactivation gating. Circ Res. 1994;75:114-122.
132. El-Sherif N, Fozzard HA, Hanck DA. Dose-dependent modulation of the cardiac sodium channel by sea anemone toxin ATXII. Circ Res. 1992;70:285-301.
133. Thandroyen FT, Morris AC, Hagler HK, Ziman B, Pai L, Willerson JT, Buja LM. Intracellular calcium transients and arrhythmia in isolated heart cells. Circ Res. 1991;69:810-819.
134. 1 subunit of the rat brain sodium channel. Science. 1992;256:839-842.
135. 1 subunit mRNA expressed in adult human skeletal muscle, heart, and brain is encoded by a single gene. J Biol Chem. 1994; 269:7571-7578.
136. 1 subunit with human cardiac (hH1) and rat skeletal muscle (μ1) sodium channel α subunits expressed in Xenopus oocytes. J Gen Physiol. 1995;106: 1171-1191.
137. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation. 1995;92:1336-1347.
138. Watkins H, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet. 1995;4:1721-1727.
139. Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1108-1114.
140. Ahn AH, Kunkel LM. The structural and functional diversity of dystrophin. Nat Genet. 1993;3:283-291.
141. Matsumura K, Campbell KP. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve. 1994;17:2-15.
142. Wallace AA, Stupienski RF III, Brookes LM, Selnick HG, Claremon DA, Lynch JJ Jr. Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized dogs. J Cardiovasc Pharmacol. 1991;18:687-695.
143. Campbell RM, Woosley RL, Iansmith DH, Roden DM. Lack of triggered automaticity despite repolarization abnormalities due to bepridil and lidoflazine. Pacing Clin Electrophysiol. 1990;13:30-36.
144. o-induced electrical heterogeneity and extrasystolic activity in isolated canine ventricular epicardium. Circulation. 1994;89:1839-1850.
145. Kihara Y, Morgan JP. Intracellular calcium and ventricular fibrillation: studies in the aequorin-loaded isovolumic ferret heart. Circ Res. 1991;68:1378-1389.
146. Ogawa S, Barnett JV, Sen L, Galper JB, Smith TW, Marsh JD. Direct contact between sympathetic neurons and rat cardiac myocytes in vitro increases expression of functional calcium channels. J Clin Invest. 1992;89:1085-1093.
147. Amlicke JD, Picklo M, Schmidt D, Robertson D, Roden DM. QT prolongation in a new model of sympathetic inhibition. Circulation. 1994;90(suppl I):I-518. Abstract.
148. Malfatto G, Rosen TS, Steinberg SF, Ursell PC, Sun LS, Daniel S, Danilo P Jr, Rosen MR. Sympathetic neural modulation of cardiac impulse initiation and repolarization in the newborn rat. Circ Res. 1990;66:427-437.
149. Christiansen JL, Stadt HA, Mulroy MJ, Kirby ML. Electrocardiographic QT prolongation after ablation of the nodose placode in the chick embryo: a developmental model of the idiopathic long QT syndrome. Pediatr Res. 1989;26:11-15.
150. Stramba-Badiale M, Lazzarotti M, Schwartz PJ. Development of cardiac innervation, ventricular fibrillation, and sudden infant death syndrome. Am J Physiol. 1992;263:H1514-H1522.
151. Ks contributes to the longer action potential of the M cell. Circ Res. 1995;76:351-365.
152. Litovsky SH, Antzelevitch C. Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res. 1988;62:116-126.
153. Furukawa T, Kimura S, Furukawa N, Bassett AL, Myerburg RJ. Potassium rectifier currents differ in myocytes of endocardial and epicardial origin. Circ Res. 1992;70:91-103.
154. TO. Am J Physiol. 1991;260:H1501-H1506.
155. Näbauer M, Beuckelmann DJ, Überfuhr P, Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation. 1996;93:168-177.
156. Kr subunit. Circulation. 1995;92(suppl I):I-373. Abstract.
157. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73:379-385.
158. Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, Kass D, Feldman AM, Marban E. Sudden cardiac death in heart failure: the role of abnormal repolarization. Circulation. 1994;90:2534-2539.
159. Aronson RS. Mechanisms of arrhythmias in ventricular hypertrophy. J Cardiovasc Electrophysiol. 1991;2:249-261.
160. Doggrell S, Hoey A, Brown L. Ion channel modulators as potential positive inotropic compound for treatment of heart failure. Clin Exp Pharmacol Physiol. 1994;21:833-843.
161. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation. 1991;84:1831-1851.
162. Roden DM, George AL Jr, Bennett PB. Recent advances in understanding the molecular mechanisms of the long QT syndrome. J Cardiovasc Electrophysiol. 1995;6:1023-1031.
163. + channel alpha-subunit gene (SCN5A) to band 3p21. Cytogenet Cell Genet. 1995;68:67-70.
164. 2+ channel (CACNL1A1) to chromosome 12p13.2-pter using a dinucleotide repeat. Genomics. 1992;14:206-207.
165. Stoffel M, Espinosa R III, Powell KL, Philipson LH, Le Beau MM, Bell GI. Human G-protein-coupled inwardly rectifying potassium channel (GIRK1) gene (KCNJ3): localization to chromosome 2 and identification of a simple tandem repeat polymorphism. Genomics. 1994;21:254-256.
166. + channel gene KCNA4/Kv1.4 to mouse chromosome 2/human 11p14 and mapping of KCNCl/Kv3.1 to mouse 7/human 11p14.3-p15.2 and KCNA1/ Kv1.1 to human 12p13. Genomics. 1994;20:191-202.
167. + channel gene. Proc Natl Acad Sci U S A. 1990;87:9411-9415.
168. Chevillard C, Attali B, Lesage F, Fontes M, Barhanin J, Lazdunski M, Mattei MG. Localization of a potassium channel gene (KCNE1) to 21q22.1-q22.2 by in situ hybridization and somatic cell hybridization. Genomics. 1993;15:243-245.
169. Wainwright BJ, Scambler PJ, Schmidtke J, Watson EA, Law HY, Farrall M, Cooke HJ, Eiberg H, Williamson R. Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature. 1985; 318:384-385.